{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:13:14Z","timestamp":1791036794386,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,2,9]],"date-time":"2008-02-09T00:00:00Z","timestamp":1202515200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s00213-008-1077-z","type":"journal-article","created":{"date-parts":[[2008,2,8]],"date-time":"2008-02-08T18:30:26Z","timestamp":1202495426000},"page":"591-600","source":"Crossref","is-referenced-by-count":13,"title":["Discriminative stimulus effects of tiagabine and related GABAergic drugs in rats"],"prefix":"10.1007","volume":"197","author":[{"given":"L. M.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. F.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Staveley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Sohal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. D.","family":"Tattersall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. H.","family":"Hutson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,9]]},"reference":[{"key":"1077_CR1","doi-asserted-by":"crossref","first-page":"38934","DOI":"10.1074\/jbc.M104318200","volume":"276","author":"CE Adkins","year":"2001","unstructured":"Adkins CE, Pillai GV, Kerby J, Bonnert TP, Haldon C, McKernan RM, Gonzalez JE, Oades K, Whiting PJ, Simpson PB (2001) a4b3d GABAA receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential. J Biol Chem 276:38934\u201338939","journal-title":"J Biol Chem"},{"key":"1077_CR2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s002130100839","volume":"157","author":"N Andrews","year":"2001","unstructured":"Andrews N, Loomis S, Blake R, Ferrigan L, Singh L, McKnight AT (2001) Effect of gabapentin-like compounds on development and maintenance of morphine-induced conditioned place preference. Psychopharmacology 157:381\u2013387","journal-title":"Psychopharmacology"},{"key":"1077_CR3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3171\/jns.1997.87.3.0409","volume":"87","author":"RW Armstrong","year":"1997","unstructured":"Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K (1997) Intrathecally administered baclofen for treatment of spasticity of cerebral origin. J Neurosurg 87:409\u2013414","journal-title":"J Neurosurg"},{"key":"1077_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0922-4106(94)90089-2","volume":"269","author":"LA Borden","year":"1994","unstructured":"Borden LA, Dhar TGM, Smith KE, Weinshank RL, Branchek TA, Gluchowski C (1994) Tiagabine, SK&F 89976-A, CI-966 and NNC-711 are selective for the cloned GABA transporter GAT-1. Eur J Pharmacol (Molecular Pharmacology Section) 269:219\u2013244","journal-title":"Eur J Pharmacol (Molecular Pharmacology Section)"},{"key":"1077_CR5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1471-4159.1990.tb01919.x","volume":"54","author":"C Braestrup","year":"1990","unstructured":"Braestrup C, Nielsen EB, Sonnewald U, Knutsen LJ, Andersen KE, Jansen JA, Frederiksen K, Andersen PH, Mortensen A, Suzdak P (1990) (R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier. J Neurochem 54:639\u2013647","journal-title":"J Neurochem"},{"key":"1077_CR6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0028-3908(98)00066-5","volume":"37","author":"LJ Bristow","year":"1998","unstructured":"Bristow LJ, Cook GP, Patel S, Curtis N, Mawer I, Kulagowski JJ (1998) Discriminative stimulus properties of the putative dopamine D3 receptor agonist, (+)-PD 128907: role of presynaptic dopamine D2 autoreceptors. Neuropharmacology 37:793\u2013802","journal-title":"Neuropharmacology"},{"issue":"suppl 6","key":"1077_CR7","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1111\/j.1528-1157.1995.tb06015.x","volume":"36","author":"MJ Brodie","year":"1995","unstructured":"Brodie MJ (1995) Tiagabine pharmacology in profile. Epilepsia 36(suppl 6):S7\u2013S9","journal-title":"Epilepsia"},{"key":"1077_CR8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.bjp.0704795","volume":"136","author":"N Brown","year":"2002","unstructured":"Brown N, Kerby J, Bonnert TP, Whiting PJ, Wafford KA (2002) Pharmacological characterization of a novel cell lines expressing human a4b3d GABAA receptors. Br J Pharmacol 136:965\u2013974","journal-title":"Br J Pharmacol"},{"key":"1077_CR9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1124\/jpet.103.062950","volume":"309","author":"LP Carter","year":"2004","unstructured":"Carter LP, Unzeitig AW, Wu H, Chen W, Coop A, Koek W, France CP (2004) The discriminative stimulus effects of g-hydroxybutyrate and related compounds in rats discriminating baclofen or diazepam: the role of GABAA and GABAB receptors. J Pharmacol Exp Ther 309:540\u2013547","journal-title":"J Pharmacol Exp Ther"},{"key":"1077_CR10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/sj.bjp.0703717","volume":"131","author":"F Crestani","year":"2000","unstructured":"Crestani F, Martin JR, Mohler H, Rudolph U (2000) Mechanism of action of the hypnotic zolpidem in vivo. Br J Pharmacol 131:1251\u20131254","journal-title":"Br J Pharmacol"},{"key":"1077_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568026053386962","volume":"5","author":"P Czapinski","year":"2005","unstructured":"Czapinski P, Blaszczyk B, Czuczwar SJ (2005) Mechanisms of action of antiepileptic drugs. Current Topics in Medicinal Chemistry 5:3\u201314","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"1077_CR12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0920-1211(97)00031-4","volume":"28","author":"NO Dalby","year":"1997","unstructured":"Dalby NO, Nielsen EB (1997) Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin. Epilepsy Res 28:63\u201372","journal-title":"Epilepsy Res"},{"key":"1077_CR13","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1124\/mol.58.4.756","volume":"58","author":"M Davies","year":"2000","unstructured":"Davies M, Newell JG, Derry JMC, Martin IL, Dunn SMJ (2000) Characterization of the interaction of zopiclone with \u03b3-aminobutyric acid type A receptors. Mol Pharmacol 58:756\u2013762","journal-title":"Mol Pharmacol"},{"key":"1077_CR14","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/sj.bjp.0701320","volume":"121","author":"MJ Field","year":"1997","unstructured":"Field MJ, Oles RJ, Lewis AS, McCleary S, Hughes J, Singh L (1997) Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol 121:1513\u20131522","journal-title":"Br J Pharmacol"},{"key":"1077_CR15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/jpet.103.063487","volume":"311","author":"AC Foster","year":"2004","unstructured":"Foster AC, Pelleymounter MA, Cullen MJ, Lewis D, Joppa M, Chen TK, Bozigian HP, Gross RS, Gogas KR (2004) In vivo characterization of indiplon, a novel pyrazolopyrimidine sedative-hypnotic. J Pharmacol Exp Ther 311:547\u2013559","journal-title":"J Pharmacol Exp Ther"},{"key":"1077_CR16","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","volume":"271","author":"NS Gee","year":"1996","unstructured":"Gee NS, Brown JP, Dissanayake VUK, Offord J, Thrulow R, Woodruff GN (1996) The novel anticonvulsant drug, gabapentin (neurontin), binds to the a2d subunit of a calcium channel. J Biol Chem 271:5768\u20135776","journal-title":"J Biol Chem"},{"key":"1077_CR17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0091-3057(94)90104-X","volume":"47","author":"DM Grech","year":"1994","unstructured":"Grech DM, Balster RL (1994) Discriminative stimulus effects of presynaptic GABA agonists in pentobarbital-trained rats. Pharmacol Biochem Behav 47:5\u201311","journal-title":"Pharmacol Biochem Behav"},{"key":"1077_CR18","first-page":"339","volume":"129","author":"DM Grech","year":"1997","unstructured":"Grech DM, Balster RL (1997) The discriminative stimulus effects of muscimol in rats. Psychopharmacology 129:339\u2013347","journal-title":"Psychopharmacology"},{"key":"1077_CR19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0091-3057(97)00413-9","volume":"59","author":"HE Jones","year":"1998","unstructured":"Jones HE, Balster RL (1998) Muscimol-like discriminative stimulus effects of GABA agonists in rats. Pharmacol Biochem Behav 59:319\u2013326","journal-title":"Pharmacol Biochem Behav"},{"key":"1077_CR20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1242\/jeb.196.1.283","volume":"196","author":"F Jursky","year":"1994","unstructured":"Jursky F, Tamura S, Tamura A, Mandiyan S, Nelson H, Nelson NM (1994) Structure, function and brain localisation of neurotransmitter transporters. J Exp Biol 196:283\u2013295","journal-title":"J Exp Biol"},{"key":"1077_CR21","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/sj.bjp.0701769","volume":"123","author":"M Lancel","year":"1998","unstructured":"Lancel M, Faulhaber J, Deisz RA (1998) Effect of the GABA uptake inhibitor tiagabine on sleep and EEG power spectra in the rat. Br J Pharmacol 123:1471\u20131477","journal-title":"Br J Pharmacol"},{"key":"1077_CR22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(97)05035-6","volume":"351","author":"JP Leach","year":"1998","unstructured":"Leach JP, Brodie MJ (1998) Tigabine. Lancet 351:203\u2013207","journal-title":"Lancet"},{"key":"1077_CR23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1037\/1064-1297.8.3.294","volume":"8","author":"S Lelas","year":"2000","unstructured":"Lelas S, Spealman RD, Rowlett JK (2000) Using behavior to elucidate receptor mechanisms: a review of the discriminative stimulus effects of benzodiazepines. Exp Clin Psychopharmacol 8:294\u2013311","journal-title":"Exp Clin Psychopharmacol"},{"key":"1077_CR24","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.neuropharm.2005.11.011","volume":"50","author":"JL Liang","year":"2006","unstructured":"Liang JL, Chen F, Krstew E, Cowen MS, Carroll FY, Crawford D, Beart PM, Lawrence AJ (2006) The GABA(B) receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. Neuropharmacology 50:632\u2013639","journal-title":"Neuropharmacology"},{"key":"1077_CR25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0304-3940(91)90249-S","volume":"128","author":"W L\u00f6scher","year":"1991","unstructured":"L\u00f6scher W, H\u00f6nack D, Taylor CP (1991) Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci Lett 128:150\u2013154","journal-title":"Neurosci Lett"},{"key":"1077_CR26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0091-3057(03)00081-9","volume":"75","author":"J Luszczki","year":"2003","unstructured":"Luszczki J, Swiader M, Czuczwar M, Kis J, Czuczwar SJ (2003) Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice. Pharmacol Biochem Behav 75:319\u2013327","journal-title":"Pharmacol Biochem Behav"},{"key":"1077_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/mcne.1998.0698","volume":"12","author":"B Malitschek","year":"1998","unstructured":"Malitschek B, Ruegg D, Heid J, Kaupmann K, Bittiger H, Frostl W, Bettler B, Kuhn R (1998) Developmental changes of agonist affinity at GABABR1 receptor variants in rat brain. Mol Cell Neurosci 12:56\u201364","journal-title":"Mol Cell Neurosci"},{"key":"1077_CR28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0197-4580(00)00232-3","volume":"22","author":"S Mathias","year":"2001","unstructured":"Mathias S, Wetter TC, Steiger A, Lancel M (2001) The GABA uptake inhibitor tiagabine promotes slow wave sleep in normal elderly subjects. Neurobiol Aging 22:247\u2013253","journal-title":"Neurobiol Aging"},{"key":"1077_CR29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0304-3940(79)91481-2","volume":"12","author":"R Maurer","year":"1979","unstructured":"Maurer R (1979) The GABA agonist THIP, a muscimol analogue, does not interfere with the benzodiazepine binding site on rats\u2019 cortical membranes. Neurosci Lett 12:65\u201368","journal-title":"Neurosci Lett"},{"key":"1077_CR30","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuropharm.2006.10.009","volume":"52","author":"LM McDonald","year":"2007","unstructured":"McDonald LM, Sheppard WF, Staveley SM, Sohal B, Tattersall FD, Hutson PH (2007) Gaboxadol, a selective extrasynaptic GABA A agonist, does not generalise to other sleep-enhancing drugs: a rat drug discrimination study. Neuropharmacology 52:844\u2013853","journal-title":"Neuropharmacology"},{"key":"1077_CR31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0091-3057(95)02025-X","volume":"53","author":"RK McNamara","year":"1996","unstructured":"McNamara RK, Skelton RW (1996) Baclofen, a selective GABAB receptor agonist, dose-dependently impairs spatial learning in rats. Pharmacol Biochem Behav 53:303\u2013308","journal-title":"Pharmacol Biochem Behav"},{"key":"1077_CR32","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/0024-3205(83)90293-X","volume":"33","author":"EB Nielsen","year":"1983","unstructured":"Nielsen EB, Valentine JD, Holohean AM, Appel JB (1983) Benzodiazepine receptor mediated discriminative cues: effects of GABA-ergic drugs and inverse agonists. Life Sci 33:2213\u20132220","journal-title":"Life Sci"},{"key":"1077_CR33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-2999(91)90438-V","volume":"196","author":"EB Nielsen","year":"1991","unstructured":"Nielsen EB, Suzdak PD, Andersen KE, Knutsen LJS, Sonnewald U, Braestrup C (1991) Characterisation of tiagabine (NO-328), a new, potent and selective GABA uptake inhibitor. Eur J Pharmacol 196:257\u2013266","journal-title":"Eur J Pharmacol"},{"key":"1077_CR34","first-page":"253","volume":"2","author":"DA Overton","year":"1991","unstructured":"Overton DA (1991) Historical context of state dependent learning and discriminative drug effects. Behav Pharmacol 2:253\u2013264","journal-title":"Behav Pharmacol"},{"key":"1077_CR35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/026988118700100203","volume":"2","author":"RJ Rauch","year":"1987","unstructured":"Rauch RJ, Stolerman IP (1987) Midazolam cue in rats: effects of drugs acting on GABA and 5-hydroxytryptamine systems, anticonvulsants and sedatives. J Psychopharmacol 2:71\u201380","journal-title":"J Psychopharmacol"},{"key":"1077_CR36","first-page":"312","volume":"22","author":"SC Schachter","year":"1999","unstructured":"Schachter SC (1999) A review of the antiepileptic drug tiagabine. Clin Neuropharmacol 22:312\u2013317","journal-title":"Clin Neuropharmacol"},{"key":"1077_CR37","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","volume":"6","author":"GJ Sills","year":"2006","unstructured":"Sills GJ (2006) The mechanisms of action of gabapentin and pregabalin. Current Opinion Pharmacology 6:108\u2013113","journal-title":"Current Opinion Pharmacology"},{"key":"1077_CR38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0014-2999(94)00696-5","volume":"273","author":"SE Smith","year":"1995","unstructured":"Smith SE, Parvez NS, Chapman AG, Meldrum BS (1995) The g-aminobutyric acid uptake inhibitor, tiagabine, is anticonvulsant in two animal models of reflex epilepsy. Eur J Pharmacol 273:259\u2013265","journal-title":"Eur J Pharmacol"},{"key":"1077_CR39","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1124\/jpet.105.092403","volume":"316","author":"S Storustovu","year":"2006","unstructured":"Storustovu S, Ebert B (2006) Pharmacological characterisation of agonists at d-containing GABAA receptors: functional selectivity for extrasynaptic receptors is dependent on absence of g2. J Pharmacol Exp Therapeut 316:1351\u20131359","journal-title":"J Pharmacol Exp Therapeut"},{"key":"1077_CR40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3940(01)02166-8","volume":"312","author":"M Tariq","year":"2001","unstructured":"Tariq M, Arshaduddin M, Biary N, Al Moutaery K, Al Deeb S (2001) Baclofen attenuates harmaline-induced tremors in rats. Neurosci Lett 312:79\u201382","journal-title":"Neurosci Lett"},{"key":"1077_CR41","first-page":"670","volume":"50","author":"KA Wafford","year":"1996","unstructured":"Wafford KA, Thompson SA, Thomas D, Sikela J, Wilcox AS, Whiting PJ (1996) Functional characterisation of human g-aminobutyric acidA receptors containing the a4 subunit. J Pharmacol Exp Therapeut 50:670\u2013678","journal-title":"J Pharmacol Exp Therapeut"},{"key":"1077_CR42","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/BF00426468","volume":"73","author":"JC Winter","year":"1981","unstructured":"Winter JC (1981) The stimulus properties of gamma-hydroxybutyrate. Psychopharmacology 73:372\u2013375","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1077-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-008-1077-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-008-1077-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T01:51:35Z","timestamp":1630720295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-008-1077-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,9]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["1077"],"URL":"https:\/\/doi.org\/10.1007\/s00213-008-1077-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,9]]}}}